This is a commentary on liquid biopsies as a minimally invasive approach across cancer care, which can lead to early detection and monitor therapeutic response. This is important as current research focuses on overcoming technical challenges and establishing clinical value by bringing together multiple fields of study. This is a publication of the Stand Up 2 Cancer-LUNGevity-American Lung Association Lung Cancer Interception Dream Team.
Join over 700,000 people who receive the latest news about lung health, including research, lung disease, air quality, quitting tobacco, inspiring stories and more!
Thank you! You will now receive email updates from the American Lung Association.